175 related articles for article (PubMed ID: 21133853)
61. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
[TBL] [Abstract][Full Text] [Related]
62. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.
Yang CT; You L; Yeh CC; Chang JW; Zhang F; McCormick F; Jablons DM
J Natl Cancer Inst; 2000 Apr; 92(8):636-41. PubMed ID: 10772681
[TBL] [Abstract][Full Text] [Related]
63. Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis.
Tokarsky-Amiel R; Azazmeh N; Helman A; Stein Y; Hassan A; Maly A; Ben-Porath I
Cancer Res; 2013 May; 73(9):2829-39. PubMed ID: 23423975
[TBL] [Abstract][Full Text] [Related]
64. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
Wang P; Rao J; Yang H; Zhao H; Yang L
J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
[TBL] [Abstract][Full Text] [Related]
65. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas.
Cortot AB; Younes M; Martel-Planche G; Guibert B; Isaac S; Souquet PJ; Commo F; Girard P; Fouret P; Brambilla E; Hainaut P; Soria JC
Clin Lung Cancer; 2014 Mar; 15(2):124-30. PubMed ID: 24169260
[TBL] [Abstract][Full Text] [Related]
66. Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression.
Shikami M; Miwa H; Nishii K; Kyo T; Tanaka I; Shiku H; Kita K; Nitta M
Leuk Res; 2006 Apr; 30(4):379-83. PubMed ID: 16162359
[TBL] [Abstract][Full Text] [Related]
67. Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin.
Deng X; Kim M; Vandier D; Jung YJ; Rikiyama T; Sgagias MK; Goldsmith M; Cowan KH
Biochem Biophys Res Commun; 2002 Aug; 296(4):792-8. PubMed ID: 12200117
[TBL] [Abstract][Full Text] [Related]
68. Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.
Edwards SJ; Dix BR; Myers CJ; Dobson-Le D; Huschtscha L; Hibma M; Royds J; Braithwaite AW
J Virol; 2002 Dec; 76(24):12483-90. PubMed ID: 12438574
[TBL] [Abstract][Full Text] [Related]
69. p400 is required for E1A to promote apoptosis.
Samuelson AV; Narita M; Chan HM; Jin J; de Stanchina E; McCurrach ME; Narita M; Fuchs M; Livingston DM; Lowe SW
J Biol Chem; 2005 Jun; 280(23):21915-23. PubMed ID: 15741165
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family.
Calabrò V; Mansueto G; Santoro R; Gentilella A; Pollice A; Ghioni P; Guerrini L; La Mantia G
Mol Cell Biol; 2004 Oct; 24(19):8529-40. PubMed ID: 15367673
[TBL] [Abstract][Full Text] [Related]
71. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
[TBL] [Abstract][Full Text] [Related]
72. p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase.
Woods YL; Xirodimas DP; Prescott AR; Sparks A; Lane DP; Saville MK
J Biol Chem; 2004 Nov; 279(48):50157-66. PubMed ID: 15355988
[TBL] [Abstract][Full Text] [Related]
73. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
[TBL] [Abstract][Full Text] [Related]
74. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism.
Rizos H; Scurr LL; Irvine M; Alling NJ; Kefford RF
Cell Cycle; 2007 Jul; 6(14):1741-7. PubMed ID: 17630509
[TBL] [Abstract][Full Text] [Related]
75. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
Li Z; Hou J; Sun L; Wen T; Wang L; Zhao X; Xie Q; Zhang SQ
Mol Biol Cell; 2012 Dec; 23(23):4635-46. PubMed ID: 23034180
[TBL] [Abstract][Full Text] [Related]
76. Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.
Vivo M; Ranieri M; Sansone F; Santoriello C; Calogero RA; Calabrò V; Pollice A; La Mantia G
PLoS One; 2013; 8(1):e53631. PubMed ID: 23308265
[TBL] [Abstract][Full Text] [Related]
77. MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.
Vivo M; Matarese M; Sepe M; Di Martino R; Festa L; Calabrò V; La Mantia G; Pollice A
PLoS One; 2015; 10(2):e0117252. PubMed ID: 25723571
[TBL] [Abstract][Full Text] [Related]
78. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
[TBL] [Abstract][Full Text] [Related]
79. Hepatitis C virus core protein overcomes H2O2-induced apoptosis by downregulating p14 expression via DNA methylation.
Seo YL; Heo S; Jang KL
J Gen Virol; 2015 Apr; 96(Pt 4):822-832. PubMed ID: 25535325
[TBL] [Abstract][Full Text] [Related]
80. High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.
Carr-Wilkinson J; O'Toole K; Wood KM; Challen CC; Baker AG; Board JR; Evans L; Cole M; Cheung NK; Boos J; Köhler G; Leuschner I; Pearson AD; Lunec J; Tweddle DA
Clin Cancer Res; 2010 Feb; 16(4):1108-18. PubMed ID: 20145180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
